US SARS-CoV-2 Seroprevalence High Based on Blood Donations
The combined severe acute respiratory syndrome coronavirus 2 seroprevalence from infection or vaccination reached an estimated 94.7 percent in December 2021.
The combined severe acute respiratory syndrome coronavirus 2 seroprevalence from infection or vaccination reached an estimated 94.7 percent in December 2021.
Women who conceive with ART have a higher risk for vascular complications and adverse obstetric outcomes compared with women who conceive without ART.
Student donors accounted for about 25 percent of donors in 2019, but for just 10 percent during the pandemic.
The objective of the study was to assess the association between psoriatic arthritis and venous thromboembolism events.
For patients with psoriasis, the risk for cancer is increased at the time of or after venous thromboembolism.
Researchers sought to determine whether vaccination against COVID-19 would increase the risk of developing deep vein thrombosis.
Researchers sought to determine whether prophylactic-intensity anticoagulation would be recommended for patients with severe COVID-19 without a confirmed or suspected case of venous thromboembolism.
Implementation of a comprehensive patient blood management program may reduce use of transfusions in hospitalized adults without compromising clinical outcomes.
Researchers aimed to provide deeper insight into the predictors of mortality and survival in patients with VEXAS syndrome.
Individuals using anticoagulation therapy on an outpatient basis who are diagnosed with COVID-19 have a reduced risk for hospital admission.